Developer docs
API playgroundTry for free, no card

Search company profiles

KaryoLogic

Full company profile

uuid000ehf1

Namestring
KaryoLogic
Legal namestring
KaryoLogic Inc.
Websiteurl
karyologic.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

KaryoLogic Inc. is a specialty cytogenetics laboratory founded in 2008 in Durham, North Carolina (Research Triangle Park) by cytogeneticist Elizabeth Gonzalez, and acquired in April 2025 by Clean Cells, part of the Clean Biologics group, where it now operates as a US-based subsidiary. The company provides chromosome analysis and biosafety testing services to academic research institutions, government laboratories, and biopharmaceutical and cell therapy developers working with human pluripotent stem cells, other human cells, and a range of non-human species (mouse, rat, pig, dog, cat, Chinese hamster, sheep, chicken).

Its core technical offering is G-band karyotyping — brief cell culture, metaphase arrest, fixation, banded slide preparation, and microscope-based analysis of 20 metaphase spreads per sample — offered in Standard and Complex tiers, with the latter including two representative images and a per-chromosome Excel table. The differentiator is the Duo iCS-Karyo package, which combines G-band karyotyping with a 24-probe digital PCR assay (run in partnership with Stem Genomics) covering the most common abnormalities in hPSCs, including the chromosome 20q11.21 amplification that is too small to detect by G-band alone. Adjacent services include Fluorescence In Situ Hybridization (FISH), non-human species karyotyping, and — launched in 2025 — microbiology and viral safety testing (sterility, mycoplasma detection by qPCR covering 120+ strains, and HIV/HTLV/HBV/HCV qPCR screening). Work is performed in a GLP-compliant environment for RUO workflows; GMP-grade release testing and advanced assays (retrovirus, RCAAV, RCL, TEM) are routed through Clean Cells France.

The business model is B2B professional services: quote-based unit pricing per sample, with academic, non-profit, government, and volume discounts, plus fees for rush turnaround, additional images, additional spreads, cryopreserved-sample handling, and add-on digital PCR. Customer acquisition is direct and unscaled — website quote request, order form, email, and free local courier pickup across Durham, Wake, and Orange County NC, with overnight shipping for global clients. With 1-10 employees, no disclosed revenue, and no funding rounds on record, KaryoLogic is a niche specialist lab whose growth and reach now depend on integration into the Clean Biologics platform.

Short descriptiontext

KaryoLogic is a Durham, NC specialty cytogenetics lab offering G-band karyotyping, FISH, digital PCR (Duo iCS-Karyo with Stem Genomics), and biosafety testing for academic, government, and cell therapy clients; acquired by Clean Cells in April 2025.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cytogenetic testing services, chromosome karyotyping, stem cell analysis, microbial safety testing, genetic integrity verification
Industry3 codes
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Cytogenetic Testing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cytogenetic Testing Services
TypeProfessional Services
Description

Laboratory testing services for chromosome karyotyping, digital PCR, FISH, and safety testing. Services include base analysis with additional fees for rush turnaround, extra images, additional spreads, cryopreserved sample processing, and add-on digital PCR assays. Pricing is quote-based with discounts for academic, non-profit, and government labs, plus volume discounts.

karyologic.com
2Sample Analysis Add-ons
TypeProfessional Services
Description

Additional fees for cryopreserved sample processing (with longer turnaround), rush service, additional images, additional metaphase spreads analyzed, and digital PCR assay add-on to standard karyotyping.

karyologic.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details4 tiers
1Standard G-band Karyotyping - 20 metaphase spreads analyzed
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Includes chromosome count, gender information, aberration description, written summary, one representative karyotype image. Typical turnaround 15 business days.

karyologic.com
2Complex G-band Karyotyping - 20 metaphase spreads with detailed analysis
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Includes two representative karyotype images and Excel table listing details of every chromosome of each spread.

karyologic.com
3Duo iCS-Karyo Package - Combined G-band karyotyping and digital PCR
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Performs both G-band karyotype analysis and digital PCR assay (24 probes for hPSC abnormalities) from one cell sample submission. Turnaround approximately 10 working days.

karyologic.com
4Safety Testing Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Includes sterility testing, mycoplasma detection (120+ strains by qPCR), and human virus screening (HIV, HTLV, HBV, HCV). RUO testing at Durham NC; GMP-grade testing available via Clean Cells France.

karyologic.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

KaryoLogic is a contract cytogenetics laboratory that performs G-band chromosome karyotyping (Standard and Complex analyses of 20 metaphase spreads), Fluorescence In Situ Hybridization (FISH), and digital PCR assays on human and non-human cell samples submitted by research institutions, biopharmaceutical companies, and cell therapy developers. The firm also provides biosafety testing including sterility, mycoplasma detection (120+ strains by qPCR), and human virus screening (HIV, HTLV, HBV, HCV), and operates in a GLP-compliant laboratory in Durham, NC.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Detection of genetic aberrations down to 5-10 Megabases via G-band karyotyping
+3 more records
Product overview1 text field

KaryoLogic offers a portfolio of laboratory testing services focused on cytogenetic analysis and biosafety testing. The core offerings include G-band chromosome karyotyping services (Standard and Complex) across human stem cells, human non-stem cells, and non-human species (mouse, pig, cat, dog, Chinese hamster, rat, sheep, chicken), Fluorescence In Situ Hybridization (FISH) analysis, and the Duo iCS-Karyo combination package that pairs G-band karyotyping with digital PCR (via Stem Genomics partnership). The company has recently expanded into safety testing services including sterility testing, mycoplasma detection by qPCR (covering 120+ strains), and human virus screening by qPCR (HIV, HTLV, HBV, HCV). Services are offered at Research Use Only (RUO) level from Durham, NC, with GMP-grade certified release testing available through Clean Cells France.

Product and service9 records
1Standard G-band Chromosome Analysis
CategoryCytogenetic testing
Description

Cytogenetic analysis service for human (and other) cell samples that includes brief cell culture, metaphase arrest, cell fixation, stained/banded slide preparation, and microscope analysis of 20 metaphase chromosome spreads. Detects defects down to 5–10 Megabases including deletions, additions, breaks, translocations, trisomies, monosomies, duplications, inversions, isochromosomes, and polyploidy. Report includes chromosome count, gender information, description of aberrations, written summary, and one representative karyotype image; typical turnaround 15 business days; performed in a GLP-compliant environment. Designed for stem cell and other research laboratories.

2Complex G-band Chromosome Analysis
CategoryCytogenetic testing
Description

Enhanced G-band karyotyping service that analyzes 20 metaphase spreads and provides two representative karyotype images plus an Excel table listing details of every chromosome of each of the 20 spreads. Built for human non-stem cell samples requiring more detail than the Standard analysis.

3Duo iCS-Karyo Package
CategoryCombined cytogenetic and molecular testing
Description

Combination package that performs both G-band karyotype analysis and a digital PCR assay (24 probes for the most frequent abnormalities in human pluripotent stem cells) from a single cell sample submission, in conjunction with partner Stem Genomics. Includes assessment of chromosome 20q11.21 band amplification (too small to be detected by G-band karyotyping) found in more than 20% of worldwide cultured hPSCs. Final analysis emailed within approximately 10 working days of receipt of live cells. Designed to verify genomic integrity of human pluripotent stem cells.

4Human Non-Stem Cell Karyotyping
CategoryCytogenetic testing
Description

G-band chromosome analysis service for human cell samples that are not stem cells, available in Standard or Complex analysis options. Includes brief cell culture, processing to arrest cells in metaphase, cell fixation, preparation of stained/banded slides, and microscope analysis of karyotypes of chromosome spreads.

5Non-Human Species Karyotyping
CategoryCytogenetic testing
Description

Karyotyping service for multiple species including mouse, pig, cat, dog, Chinese hamster, rat, sheep, and chicken. KaryoLogic attempts to karyotype other species not on the standard list using customer-provided published karyotypes as reference.

6Fluorescence In Situ Hybridization (FISH)
CategoryCytogenetic testing
Description

DNA probe hybridization analysis on metaphase chromosome spreads. Capabilities include point probes or whole chromosome paint probes, single or dual probe analysis, with a third fluorescent color for chromosome counterstain.

7Sterility Testing
CategoryBiosafety testing
Description

Quality control testing ensuring cell cultures and biologics are free from bacterial and fungal contamination by direct inoculation using nutrient-rich broth media supporting growth of aerobic and anaerobic bacteria as well as fungi. Available as RUO for R&D workflows, with GMP-grade certified release testing available through Clean Cells France.

8Mycoplasma Detection (by qPCR)
CategoryBiosafety testing
Description

Validated qPCR mycoplasma panel covering more than 120 strains. Detects cell wall-free organisms that cannot be detected microscopically yet can disrupt cellular metabolism. Available for development and R&D workflows; GMP-grade testing and release documentation available via Clean Cells France.

9Human Virus Screening (by qPCR)
CategoryBiosafety testing
Description

qPCR-based virus screening service designed to protect laboratory personnel working with human-derived biological materials. Tests for HIV-1/2, HTLV-1/2, Hepatitis B, and Hepatitis C. Flexible panels for R&D needs; validated release assays provided via Clean Cells France.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-01
Description

Clean Cells, part of the Clean Biologics group, acquired KaryoLogic in April 2025. This strategic acquisition establishes Clean Cells' operational presence in the US. Clean Cells provides GMP-certified release testing, advanced biosafety profiling (retrovirus detection, gene therapy vector safety testing, TEM), and full regulatory documentation for IND and IMPD submissions through their France facility.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Stem Genomics for digital PCR assay component of the Duo iCS-Karyo package. The combined service performs both G-band karyotype analysis and Stem Genomics' digital PCR assay from one cell sample submission, covering 24 probes for the most frequent abnormalities in human pluripotent stem cells.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Clean Cells France facility provides GMP-grade microbiology and viral safety testing with full regulatory documentation for programs requiring certified release testing. Advanced capabilities include retrovirus detection, RCAAV and RCL assays, and transmission electron microscopy.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

WiCell's cytogenetic services division performs G-band karyotyping for hPSC lines and is the closest direct competitor to KaryoLogic's core offering, sharing the same target customer (stem cell researchers) and methodology.

2Cell Line Genetics
TypeDirect peer
Description

Cell Line Genetics provides karyotyping, FISH, and CNV analysis services specifically for pluripotent stem cells and cell therapy products, directly overlapping KaryoLogic's Duo iCS-Karyo and FISH service lines.

TypeDirect peer
Description

Applied StemCell offers cell line characterization services including karyotyping and genetic stability testing for research and cell therapy clients, competing head-to-head with KaryoLogic's human stem cell cytogenetic services.

TypeEmerging player
Description

CTGT provides genetic testing services specifically for cell and gene therapy programs, including cytogenetic assays relevant to hPSC and CAR-T QC workflows, intersecting with KaryoLogic's cell therapy customer base.

TypeBroad incumbent
Description

Stemcell Technologies is a larger stem cell-focused life science company that offers karyotyping and cell characterization services alongside reagents, competing with KaryoLogic on the cytogenetic service side while serving overlapping academic and cell therapy customers.

TypeEmerging player
Description

Genetic Technologies provides genomic risk assessment and cytogenetic-related testing services, operating in a broader genomics testing category that overlaps KaryoLogic's focus on chromosome analysis for research and clinical applications.

7Eurofins Lancaster Laboratories
TypeBroad incumbent
Description

Eurofins is a global testing services giant with biopharmaceutical and cell therapy QC capabilities including sterility, mycoplasma, and viral safety testing that overlap with KaryoLogic's recently launched safety testing services, though at much broader scale.

TypeBroad incumbent
Description

Charles River offers end-to-end cell therapy and biologics QC testing services including cytogenetic, sterility, mycoplasma, and viral safety testing, competing with KaryoLogic and its Clean Cells parent across the broader cell therapy services market.

TypeBroad incumbent
Description

Labcorp's central laboratory and drug development services include safety testing and cell-based assay capabilities that overlap KaryoLogic's RUO microbiology/viral safety services, serving similar biopharma and academic clients at scale.

TypeOthers
Description

Bio-Techne supplies reagents, proteins, and analytical tools used by stem cell researchers and cell therapy QC laboratories, including qPCR and cytogenetic-related reagents, making it an adjacent ecosystem participant rather than direct service competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KaryoLogic

Cytogenetic Testing Serviceskaryologic.com

KaryoLogic is a Durham, NC specialty cytogenetics lab offering G-band karyotyping, FISH, digital PCR (Duo iCS-Karyo with Stem Genomics), and biosafety testing for academic, government, and cell therapy clients; acquired by Clean Cells in April 2025.

What KaryoLogic does

KaryoLogic Inc. is a specialty cytogenetics laboratory founded in 2008 in Durham, North Carolina (Research Triangle Park) by cytogeneticist Elizabeth Gonzalez, and acquired in April 2025 by Clean Cells, part of the Clean Biologics group, where it now operates as a US-based subsidiary. The company provides chromosome analysis and biosafety testing services to academic research institutions, government laboratories, and biopharmaceutical and cell therapy developers working with human pluripotent stem cells, other human cells, and a range of non-human species (mouse, rat, pig, dog, cat, Chinese hamster, sheep, chicken).

Its core technical offering is G-band karyotyping — brief cell culture, metaphase arrest, fixation, banded slide preparation, and microscope-based analysis of 20 metaphase spreads per sample — offered in Standard and Complex tiers, with the latter including two representative images and a per-chromosome Excel table. The differentiator is the Duo iCS-Karyo package, which combines G-band karyotyping with a 24-probe digital PCR assay (run in partnership with Stem Genomics) covering the most common abnormalities in hPSCs, including the chromosome 20q11.21 amplification that is too small to detect by G-band alone. Adjacent services include Fluorescence In Situ Hybridization (FISH), non-human species karyotyping, and — launched in 2025 — microbiology and viral safety testing (sterility, mycoplasma detection by qPCR covering 120+ strains, and HIV/HTLV/HBV/HCV qPCR screening). Work is performed in a GLP-compliant environment for RUO workflows; GMP-grade release testing and advanced assays (retrovirus, RCAAV, RCL, TEM) are routed through Clean Cells France.

The business model is B2B professional services: quote-based unit pricing per sample, with academic, non-profit, government, and volume discounts, plus fees for rush turnaround, additional images, additional spreads, cryopreserved-sample handling, and add-on digital PCR. Customer acquisition is direct and unscaled — website quote request, order form, email, and free local courier pickup across Durham, Wake, and Orange County NC, with overnight shipping for global clients. With 1-10 employees, no disclosed revenue, and no funding rounds on record, KaryoLogic is a niche specialist lab whose growth and reach now depend on integration into the Clean Biologics platform.

KaryoLogic firmographics

Firmographics
Name
KaryoLogic
Legal name
KaryoLogic Inc.
Website
https://karyologic.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
1–10 employees
Short description
KaryoLogic is a Durham, NC specialty cytogenetics lab offering G-band karyotyping, FISH, digital PCR (Duo iCS-Karyo with Stem Genomics), and biosafety testing for academic, government, and cell therapy clients; acquired by Clean Cells in April 2025.
Ownership category
akta.pro rank

KaryoLogic industry classification

Industry
Product category
Cytogenetic Testing Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Cytogenetic testing services
  • Chromosome karyotyping
  • Stem cell analysis
  • Microbial safety testing
  • Genetic integrity verification

Where KaryoLogic is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices1 record

Markets served

KaryoLogic business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Cytogenetic Testing Services: Laboratory testing services for chromosome karyotyping, digital PCR, FISH, and safety testing. Services include base analysis with additional fees for rush turnaround, extra images, additional spreads, cryopreserved sample processing, and add-on digital PCR assays. Pricing is quote-based with discounts for academic, non-profit, and government labs, plus volume discounts.
  2. Sample Analysis Add-ons: Additional fees for cryopreserved sample processing (with longer turnaround), rush service, additional images, additional metaphase spreads analyzed, and digital PCR assay add-on to standard karyotyping.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard G-band Karyotyping - 20 metaphase spreads analyzed
Unit PricingPay-as-you-goComplex G-band Karyotyping - 20 metaphase spreads with detailed analysis
Unit PricingPay-as-you-goDuo iCS-Karyo Package - Combined G-band karyotyping and digital PCR
Unit PricingPay-as-you-goSafety Testing Services

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

KaryoLogic product offering

Product offering

Core offering

KaryoLogic is a contract cytogenetics laboratory that performs G-band chromosome karyotyping (Standard and Complex analyses of 20 metaphase spreads), Fluorescence In Situ Hybridization (FISH), and digital PCR assays on human and non-human cell samples submitted by research institutions, biopharmaceutical companies, and cell therapy developers. The firm also provides biosafety testing including sterility, mycoplasma detection (120+ strains by qPCR), and human virus screening (HIV, HTLV, HBV, HCV), and operates in a GLP-compliant laboratory in Durham, NC.

Product overview

KaryoLogic offers a portfolio of laboratory testing services focused on cytogenetic analysis and biosafety testing. The core offerings include G-band chromosome karyotyping services (Standard and Complex) across human stem cells, human non-stem cells, and non-human species (mouse, pig, cat, dog, Chinese hamster, rat, sheep, chicken), Fluorescence In Situ Hybridization (FISH) analysis, and the Duo iCS-Karyo combination package that pairs G-band karyotyping with digital PCR (via Stem Genomics partnership). The company has recently expanded into safety testing services including sterility testing, mycoplasma detection by qPCR (covering 120+ strains), and human virus screening by qPCR (HIV, HTLV, HBV, HCV). Services are offered at Research Use Only (RUO) level from Durham, NC, with GMP-grade certified release testing available through Clean Cells France.

Differentiator

Problem solved

Functional benefit

Products and services

  • Standard G-band Chromosome Analysis Cytogenetic analysis service for human (and other) cell samples that includes brief cell culture, metaphase arrest, cell fixation, stained/banded slide preparation, and microscope analysis of 20 metaphase chromosome spreads. Detects defects down to 5–10 Megabases including deletions, additions, breaks, translocations, trisomies, monosomies, duplications, inversions, isochromosomes, and polyploidy. Report includes chromosome count, gender information, description of aberrations, written summary, and one representative karyotype image; typical turnaround 15 business days; performed in a GLP-compliant environment. Designed for stem cell and other research laboratories.
  • Complex G-band Chromosome Analysis Enhanced G-band karyotyping service that analyzes 20 metaphase spreads and provides two representative karyotype images plus an Excel table listing details of every chromosome of each of the 20 spreads. Built for human non-stem cell samples requiring more detail than the Standard analysis.
  • Duo iCS-Karyo Package Combination package that performs both G-band karyotype analysis and a digital PCR assay (24 probes for the most frequent abnormalities in human pluripotent stem cells) from a single cell sample submission, in conjunction with partner Stem Genomics. Includes assessment of chromosome 20q11.21 band amplification (too small to be detected by G-band karyotyping) found in more than 20% of worldwide cultured hPSCs. Final analysis emailed within approximately 10 working days of receipt of live cells. Designed to verify genomic integrity of human pluripotent stem cells.
  • Human Non-Stem Cell Karyotyping G-band chromosome analysis service for human cell samples that are not stem cells, available in Standard or Complex analysis options. Includes brief cell culture, processing to arrest cells in metaphase, cell fixation, preparation of stained/banded slides, and microscope analysis of karyotypes of chromosome spreads.
  • Non-Human Species Karyotyping Karyotyping service for multiple species including mouse, pig, cat, dog, Chinese hamster, rat, sheep, and chicken. KaryoLogic attempts to karyotype other species not on the standard list using customer-provided published karyotypes as reference.
  • Fluorescence In Situ Hybridization (FISH) DNA probe hybridization analysis on metaphase chromosome spreads. Capabilities include point probes or whole chromosome paint probes, single or dual probe analysis, with a third fluorescent color for chromosome counterstain.
  • Sterility Testing Quality control testing ensuring cell cultures and biologics are free from bacterial and fungal contamination by direct inoculation using nutrient-rich broth media supporting growth of aerobic and anaerobic bacteria as well as fungi. Available as RUO for R&D workflows, with GMP-grade certified release testing available through Clean Cells France.
  • Mycoplasma Detection (by qPCR) Validated qPCR mycoplasma panel covering more than 120 strains. Detects cell wall-free organisms that cannot be detected microscopically yet can disrupt cellular metabolism. Available for development and R&D workflows; GMP-grade testing and release documentation available via Clean Cells France.
  • Human Virus Screening (by qPCR) qPCR-based virus screening service designed to protect laboratory personnel working with human-derived biological materials. Tests for HIV-1/2, HTLV-1/2, Hepatitis B, and Hepatitis C. Flexible panels for R&D needs; validated release assays provided via Clean Cells France.

Quantifiable outcome

  • Detection of genetic aberrations down to 5-10 Megabases via G-band karyotyping
  • +3 more outcomes

Companies that use KaryoLogic

Customer profile

Segments3 records

Ideal customer profiles3 records

KaryoLogic technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

KaryoLogic partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and major.

  • Clean CellscoreStrategic or Co-development Partner · 1 April 2025Clean Cells, part of the Clean Biologics group, acquired KaryoLogic in April 2025. This strategic acquisition establishes Clean Cells' operational presence in the US. Clean Cells provides GMP-certified release testing, advanced biosafety profiling (retrovirus detection, gene therapy vector safety testing, TEM), and full regulatory documentation for IND and IMPD submissions through their France facility.
  • Stem GenomicscoreTechnology or IntegrationPartnership with Stem Genomics for digital PCR assay component of the Duo iCS-Karyo package. The combined service performs both G-band karyotype analysis and Stem Genomics' digital PCR assay from one cell sample submission, covering 24 probes for the most frequent abnormalities in human pluripotent stem cells.
  • Clean Cells FrancemajorStrategic or Co-development PartnerClean Cells France facility provides GMP-grade microbiology and viral safety testing with full regulatory documentation for programs requiring certified release testing. Advanced capabilities include retrovirus detection, RCAAV and RCL assays, and transmission electron microscopy.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

KaryoLogic competitors and assessment

Company assessment

Direct peers

  • WiCell Cytogenetic Services: WiCell's cytogenetic services division performs G-band karyotyping for hPSC lines and is the closest direct competitor to KaryoLogic's core offering, sharing the same target customer (stem cell researchers) and methodology.
  • Cell Line Genetics: Cell Line Genetics provides karyotyping, FISH, and CNV analysis services specifically for pluripotent stem cells and cell therapy products, directly overlapping KaryoLogic's Duo iCS-Karyo and FISH service lines.
  • Applied StemCell: Applied StemCell offers cell line characterization services including karyotyping and genetic stability testing for research and cell therapy clients, competing head-to-head with KaryoLogic's human stem cell cytogenetic services.

Emerging players

  • CTGT (Cell Therapy Genetic Testing): CTGT provides genetic testing services specifically for cell and gene therapy programs, including cytogenetic assays relevant to hPSC and CAR-T QC workflows, intersecting with KaryoLogic's cell therapy customer base.
  • Genetic Technologies Inc: Genetic Technologies provides genomic risk assessment and cytogenetic-related testing services, operating in a broader genomics testing category that overlaps KaryoLogic's focus on chromosome analysis for research and clinical applications.

Broad incumbents

  • Stemcell Technologies: Stemcell Technologies is a larger stem cell-focused life science company that offers karyotyping and cell characterization services alongside reagents, competing with KaryoLogic on the cytogenetic service side while serving overlapping academic and cell therapy customers.
  • Eurofins Lancaster Laboratories: Eurofins is a global testing services giant with biopharmaceutical and cell therapy QC capabilities including sterility, mycoplasma, and viral safety testing that overlap with KaryoLogic's recently launched safety testing services, though at much broader scale.
  • Charles River Laboratories: Charles River offers end-to-end cell therapy and biologics QC testing services including cytogenetic, sterility, mycoplasma, and viral safety testing, competing with KaryoLogic and its Clean Cells parent across the broader cell therapy services market.
  • Labcorp Drug Development: Labcorp's central laboratory and drug development services include safety testing and cell-based assay capabilities that overlap KaryoLogic's RUO microbiology/viral safety services, serving similar biopharma and academic clients at scale.

Others

  • Bio-Techne: Bio-Techne supplies reagents, proteins, and analytical tools used by stem cell researchers and cell therapy QC laboratories, including qPCR and cytogenetic-related reagents, making it an adjacent ecosystem participant rather than direct service competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

KaryoLogic social profiles

Digital presence

KaryoLogic compliance and trust

Trust signal

Compliance1 record

KaryoLogic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KaryoLogic leadership team

Management profile

Number of profiles

Profiles4 records

KaryoLogic funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KaryoLogic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KaryoLogic

What does KaryoLogic do?

KaryoLogic is a contract cytogenetics laboratory that performs G-band chromosome karyotyping (Standard and Complex analyses of 20 metaphase spreads), Fluorescence In Situ Hybridization (FISH), and digital PCR assays on human and non-human cell samples submitted by research institutions, biopharmaceutical companies, and cell therapy developers. The firm also provides biosafety testing including sterility, mycoplasma detection (120+ strains by qPCR), and human virus screening (HIV, HTLV, HBV, HCV), and operates in a GLP-compliant laboratory in Durham, NC.

Is KaryoLogic a public or private company?

KaryoLogic is a private company. It is classified as corporate owned and is currently operating.

When was KaryoLogic founded?

KaryoLogic was founded in 2008. It employs 1 to 10 people.

Where is KaryoLogic based?

KaryoLogic is headquartered in Durham, United States, in the North America region.

How does KaryoLogic make money?

Two revenue lines are on record. Cytogenetic Testing Services are the primary driver. The others are sample Analysis Add-ons.

Who are KaryoLogic's main competitors?

Direct peers on record are WiCell Cytogenetic Services, Cell Line Genetics and Applied StemCell. Emerging players are CTGT (Cell Therapy Genetic Testing) and Genetic Technologies Inc. Broad incumbents are Stemcell Technologies, Eurofins Lancaster Laboratories, Charles River Laboratories and Labcorp Drug Development. Bio-Techne is listed as an others.

Does KaryoLogic have an API?

No public API is recorded for KaryoLogic.

What industry is KaryoLogic in?

KaryoLogic's product category is Cytogenetic Testing Services. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 541714 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals